phthalimide has been researched along with triazoles in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, H; Morita, H; Sakai, M; Sheikh, MC; Takagi, S | 1 |
| Ahmed, HEA; Aljuhani, A; Alraqa, SY; Aouad, MR; Elbadawy, HM; Ihmaid, SK; Rezki, N; Salama, SA | 1 |
2 other study(ies) available for phthalimide and triazoles
| Article | Year |
|---|---|
First synthesis of non-symmetrical "phthalimidoyl active ester" bi-dentate cross-linking reagents having an acid chloride, 2-benzothiazole, or 1-benzotriazol group.
Topics: Antigens; Benzylamines; Chlorides; Cholesterol; Cross-Linking Reagents; Esters; Phthalimides; Proteins; Substrate Specificity; Thiazoles; Triazoles | 2008 |
Design of molecular hybrids of phthalimide-triazole agents with potent selective MCF-7/HepG2 cytotoxicity: Synthesis, EGFR inhibitory effect, and metabolic stability.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; ErbB Receptors; Hep G2 Cells; Humans; MCF-7 Cells; Molecular Structure; Phthalimides; Protein Kinase Inhibitors; Structure-Activity Relationship; Triazoles | 2021 |